LEONHARDT VENTURES NEWS
BodStim Suits Up To Revolutionize Fitness And Shows Significant Promise For Enhancing Longevity
Bioelectrics is poised to be the next frontier of medical technology, and LionHeart Health is developing therapies on several important fronts. by Susan Belknapp, Senior Writer, California Business Journal Klotho. You may not have heard of it, but this protein is...
Industry Veteran Brian Lasater joins Leonhardt Ventures LLC as Chief Technology Officer
NEWS PROVIDED BY Leonhardt Ventures LLC 30th Mar, 2023, 9:00am PT Mission Viejo, CA , March 30th, 2023 /PRDistribution/ -- Leonhardt Ventures LLC announces today that Brian Lasater has joined earlier this year the firm as Chief Technology Officer. In this role, he is...
Second Heart Assist, Inc. Announces Issuance of 20 New U.S. Patent Claims Covering its Circulatory Assist Device Technology Platform
March 16th, 2023, Salt Lake City, Utah and Mission Viejo, CA - Second Heart Assist, Inc. has announced that it has obtained patent no. U.S. 11,602,627 on March 14th, 2023 from the US Patent and Trademark Office Titled “Circulatory Assist Pump” with 20 new patent...
DepressiStim Announces Clinical Trial Progress
DepressiStim TM Reports Progress on Treatment Resistant Depression Pilot Clinical Study The DepressiStim TM Brain Band therapy system is intended to be indicated for adjunctive non-invasive treatment of chronic or recurrent depression in patients who are experiencing...
Leonhardt Ventures Lands 12th Issued Patent for Bioelectric Treatment of Cancers – OPG Control
This new patent letter of allowance received from the USPTO further expands the Company's intellectual property estate intended for treating, suppressing and preventing cancer tumor formation and progression. Leonhardt Ventures LLC and its cancer treating and...
Leonhardt Ventures and Lionheart Health Announce Patent Application Filing for Bioelectric Control of SESTRINs Anti-Aging Protein Expressions
Strengthens deep pipeline of longevity and wellness intellectual property Leonhardt Ventures LLC, and its commercial distribution arm Lionheart Health, Inc., has filed a series of patent claims for bioelectric controlled expression of the SESTRINs family of anti-aging...
TremorStim Unveils 2nd Generation Combination Head and Wrist Band Bioelectric Device for Treatment of Essential Tremor
Irvine, California (Newsworthy.ai) Wednesday Nov 23, 2022 @ 4:00 AM Central — TremorStim, a Leonhardt Ventures LLC startup, unveiled today its 2nd generation combination bioelectric stimulation device for treating essential tremor comprised of an easily applied,...
U.S. Patent for Bioelectric Expression of Klotho, a Key Longevity and Disease-Fighting Protein Issued to Leonhardt Ventures
Mission Viejo, California, United States, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Leonhardt Ventures, LLC is pleased to announce the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11,471,686 covering bioelectric stimulation control of...
Howard Leonhardt Finalist for Best Technology CEO of the Year Award Orange County hosted by Octane
Irvine, CA - October 1, 2022 - Howard Leonhardt CEO of Leonhardt Ventures LLC and Leonhardt's Launchpads was a FINALIST for Best Technology CEO of the Year Award hosted by Octane https://octaneoc.org/hta-finalists-winners/. The High Tech Awards Ceremony was held...
Leonhardt Ventures LLC Patent Licenses 2022
Leonhardt Ventures LLC Patent Licenses https://patents.justia.com/inventor/howard-j-leonhardt www.lventuresnestg.wpenginepowered.com Licenses are for all patents issued and filed during period that these startups/innovation platforms were in our accelerator program,...